Bristol-Myers Squibb Co (BUE:BMY) Dividend Payout Ratio : 0.11 (As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is Bristol-Myers Squibb Co Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Bristol-Myers Squibb Co's Dividend Payout Ratio for the months ended in Sep. 2024 was 0.11.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Bristol-Myers Squibb Co is 2.05, which seems too high.

The historical rank and industry rank for Bristol-Myers Squibb Co's Dividend Payout Ratio or its related term are showing as below:

BUE:BMY' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.27 Med: 0.38 Max: 1.29
Current: 1.29

During the past 13 years, the highest Dividend Payout Ratio of Bristol-Myers Squibb Co was 1.29. The lowest was 0.27. And the median was 0.38.

BUE:BMY's Dividend Payout Ratio is ranked worse than
97.91% of 431 companies
in the Drug Manufacturers industry
Industry Median: 0.37 vs BUE:BMY: 1.29

As of today (2024-12-11), the Dividend Yield % of Bristol-Myers Squibb Co is 3.46%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Bristol-Myers Squibb Co was 5.98%. The lowest was 1.99%. And the median was 2.88%.

Bristol-Myers Squibb Co's Dividends per Share for the months ended in Sep. 2024 was ARS190.10.

During the past 12 months, Bristol-Myers Squibb Co's average Dividends Per Share Growth Rate was 5.30% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 7.90% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 8.00% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 5.10% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Bristol-Myers Squibb Co was 14.20% per year. The lowest was 0.50% per year. And the median was 3.50% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Bristol-Myers Squibb Co Dividend Payout Ratio Historical Data

The historical data trend for Bristol-Myers Squibb Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Dividend Payout Ratio Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividend Payout Ratio

Get a 7-Day Free Trial

0.36

0.14

0.05

0.10

Bristol-Myers Squibb Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Dividend Payout Ratio	Get a 7-Day Free Trial															0.10	0.12	-	0.10	0.11

Competitive Comparison of Bristol-Myers Squibb Co's Dividend Payout Ratio

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bristol-Myers Squibb Co's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Dividend Payout Ratio falls into.

Bristol-Myers Squibb Co Dividend Payout Ratio Calculation

Bristol-Myers Squibb Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2023 )	/	EPS without NRI (A: Dec. 2023 )
	=	277.97	/	2711.11
	=	0.10

Bristol-Myers Squibb Co's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Sep. 2024 )	/	EPS without NRI (Q: Sep. 2024 )
	=	190.1	/	1710.9
	=	0.11

Bristol-Myers Squibb Co (BUE:BMY) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Bristol-Myers Squibb Co Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (BUE:BMY) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BRM:Germany BRM:Germany BRM:Germany BMYB34:Brazil BMYS:Austria

Address

Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.